BACKGROUND & AIMS: Impairment of sleep quality is common in patients with inflammatory bowel diseases (IBDs) (eg, Crohn's disease [CD] and ulcerative colitis [UC]), even during clinical remission. Sleep impairment can activate inflammatory pathways. Few prospective studies have examined the role of sleep disturbance on risk of relapse in IBD. METHODS: We analyzed data from 3173 patients with IBD (1798 in clinical remission at baseline) participating in the Crohn's and Colitis Foundation of America Partners study, a longitudinal, Internet-based cohort. Sleep disturbance was measured using a subset of questions from the Patient Reported Outcomes Measurement Information Systems sleep disturbance questionnaire. Disease activity was assessed using the short Crohn's Disease Activity Index and the simple clinical colitis activity index for CD and UC, respectively. Logistic regression was used to identify predictors of sleep quality and examine the effect of sleep quality at baseline among patients in remission on risk of active disease at 6 months. RESULTS: Disease activity, depression, female sex, smoking, and use of corticosteroids or narcotics were associated with sleep disturbance at enrollment. Among 1291 patients whose CD was in remission at baseline, those with impaired sleep had a 2-fold increase in risk of active disease at 6 months (adjusted odds ratio, 2.00; 95% confidence interval, 1.45-2.76); however, no effect was observed in patients with UC (odds ratio, 1.14; 95% confidence interval, 0.75-1.74). These findings persisted in a number of sensitivity analyses. CONCLUSIONS: Sleep disturbance was associated with an increased risk of disease flares in CD but not UC. These findings indicate that the evaluation and treatment of sleep disturbance in patients with CD might improve outcomes.
BACKGROUND & AIMS:Impairment of sleep quality is common in patients with inflammatory bowel diseases (IBDs) (eg, Crohn's disease [CD] and ulcerative colitis [UC]), even during clinical remission. Sleep impairment can activate inflammatory pathways. Few prospective studies have examined the role of sleep disturbance on risk of relapse in IBD. METHODS: We analyzed data from 3173 patients with IBD (1798 in clinical remission at baseline) participating in the Crohn's and Colitis Foundation of America Partners study, a longitudinal, Internet-based cohort. Sleep disturbance was measured using a subset of questions from the Patient Reported Outcomes Measurement Information Systems sleep disturbance questionnaire. Disease activity was assessed using the short Crohn's Disease Activity Index and the simple clinical colitis activity index for CD and UC, respectively. Logistic regression was used to identify predictors of sleep quality and examine the effect of sleep quality at baseline among patients in remission on risk of active disease at 6 months. RESULTS: Disease activity, depression, female sex, smoking, and use of corticosteroids or narcotics were associated with sleep disturbance at enrollment. Among 1291 patients whose CD was in remission at baseline, those with impaired sleep had a 2-fold increase in risk of active disease at 6 months (adjusted odds ratio, 2.00; 95% confidence interval, 1.45-2.76); however, no effect was observed in patients with UC (odds ratio, 1.14; 95% confidence interval, 0.75-1.74). These findings persisted in a number of sensitivity analyses. CONCLUSIONS:Sleep disturbance was associated with an increased risk of disease flares in CD but not UC. These findings indicate that the evaluation and treatment of sleep disturbance in patients with CD might improve outcomes.
Authors: Lesley A Graff; Norah Vincent; John R Walker; Ian Clara; Rachel Carr; Jason Ediger; Norine Miller; Linda Rogala; Patricia Rawsthorne; Lisa Lix; Charles N Bernstein Journal: Inflamm Bowel Dis Date: 2010-12-22 Impact factor: 5.325
Authors: Nicolino Ruperto; Daniel J Lovell; Tracy Li; Flavio Sztajnbok; Claudia Goldenstein-Schainberg; Morton Scheinberg; Inmaculada Calvo Penades; Michael Fischbach; Javier Orozco Alcala; Philip J Hashkes; Christine Hom; Lawrence Jung; Loredana Lepore; Sheila Oliveira; Carol Wallace; Maria Alessio; Pierre Quartier; Elisabetta Cortis; Anne Eberhard; Gabriele Simonini; Irene Lemelle; Elizabeth Candell Chalom; Leonard H Sigal; Alan Block; Allison Covucci; Marleen Nys; Alberto Martini; Edward H Giannini Journal: Arthritis Care Res (Hoboken) Date: 2010-07-01 Impact factor: 4.794
Authors: Kalliopi Fragiadaki; Maria G Tektonidou; Maria Konsta; George P Chrousos; Petros P Sfikakis Journal: J Rheumatol Date: 2011-12-01 Impact factor: 4.666
Authors: Lan Yu; Daniel J Buysse; Anne Germain; Douglas E Moul; Angela Stover; Nathan E Dodds; Kelly L Johnston; Paul A Pilkonis Journal: Behav Sleep Med Date: 2011-12-28 Impact factor: 2.964
Authors: Millie D Long; Michael D Kappelman; Christopher F Martin; Wenli Chen; Kristen Anton; Robert S Sandler Journal: J Clin Gastroenterol Date: 2016-02 Impact factor: 3.062
Authors: Parth J Parekh; Edward C Oldfield Iv; Vaishnavi Challapallisri; J Catsby Ware; David A Johnson Journal: Am J Gastroenterol Date: 2014-08-26 Impact factor: 10.864
Authors: René Pagel; Florian Bär; Torsten Schröder; Annika Sünderhauf; Axel Künstner; Saleh M Ibrahim; Stella E Autenrieth; Kathrin Kalies; Peter König; Anthony H Tsang; Dominik Bettenworth; Senad Divanovic; Hendrik Lehnert; Klaus Fellermann; Henrik Oster; Stefanie Derer; Christian Sina Journal: FASEB J Date: 2017-07-14 Impact factor: 5.191
Authors: Arlene E Chung; Robert S Sandler; Millie D Long; Sean Ahrens; Jessica L Burris; Christopher F Martin; Kristen Anton; Amber Robb; Thomas P Caruso; Elizabeth L Jaeger; Wenli Chen; Marshall Clark; Kelly Myers; Angela Dobes; Michael D Kappelman Journal: J Am Med Inform Assoc Date: 2016-01-28 Impact factor: 4.497
Authors: Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands Journal: Inflamm Bowel Dis Date: 2014-02 Impact factor: 5.325
Authors: Millie D Long; R Jean Cadigan; Suzanne F Cook; Kaaren Haldeman; Kriste Kuczynski; Robert S Sandler; Christopher F Martin; Wenli Chen; Michael D Kappelman Journal: Inflamm Bowel Dis Date: 2015-01 Impact factor: 5.325